stars 1 stars 2 stars 3

Phebra is one of Australia’s largest privately-owned pharmaceutical groups, with a manufacturing facility in Sydney which develops, produces and markets critical medicines in Australia and across the world. Since 1993, Phebra has built a reputation for innovation, product development and manufacture of over 65 medicines in critical therapeutic disease areas such as cystic fibrosis, antidotes, diagnostics, oncology and pain. Being dynamic and innovative, Phebra collaborates with healthcare providers to research, develop and produce critical medicines to meet unmet needs.

Phebra Pty Ltd Questions

The Phebra Pty Ltd annual revenue was $30.4 million in 2026.

Andre Vlok is the CEO of Phebra Pty Ltd.

78 people are employed at Phebra Pty Ltd.

Phebra Pty Ltd is based in Lane Cove West, New South Wales.

The NAICS codes for Phebra Pty Ltd are [325, 3254, 32, 32541].

The SIC codes for Phebra Pty Ltd are [283, 28].

Top Phebra Pty Ltd Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users